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Executive Summary 
 
Hundreds of thousands of veterans of the wars in Iraq 
and Afghanistan are returning with post-traumatic stress 
disorder (PTSD),1 traumatic brain injury (TBI),2 and 
other illnesses and injuries3 that often contribute to 
substance abuse and addiction,4,5 fatal overdose,6 
homelessness7 and suicide.8 The current generation of 
veterans joins the large population of Vietnam-era 
veterans who have struggled with the same problems for 
decades.9  
 
Left untreated, these underlying medical conditions 
often contribute to violations of the law, especially 
nonviolent drug offenses.10   Veterans returning from 
the wars in Iraq and Afghanistan run a high risk of 
becoming casualties of America’s longest and most 
costly war: the war on drugs. Effective treatments to 
treat drug misuse and addiction, as well as PTSD and 
other service-related conditions, meanwhile, are often 
underutilized or prohibited as a result of entrenched 
drug war policies codified at the local, state and federal 
levels.  
 
This policy brief highlights some less-discussed but 
deeply troubling issues affecting veterans that are caused 
or exacerbated by the drug war – and proposes proven, 
commonsense and cost-effective solutions to improve 
the health, reduce the likelihood of accidental death, and 
preserve the freedom of those who have served in our 
armed forces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of Recommendations  
 
 The United States Department of Veterans Affairs 
(VA) and Department of Defense (DoD) must 
adopt overdose prevention programs and policies 
targeting veterans and service members who misuse 
alcohol and other drugs, or who take prescription 
medications, especially opioid analgesics. 
 
 Veteran treatment programs must greatly expand 
access to medication-assisted therapies like 
methadone and buprenorphine, which are the most 
effective means of treating opioid dependence. 
 
 State and federal governments must modify 
sentencing statutes and improve court-ordered drug 
diversion programs to better treat – rather than 
criminalize and incarcerate – veterans who commit 
drug law violations. State and federal governments 
should expand community-based treatment options 
and explore pre-arrest diversion programs to help 
veterans before they enter the justice system. 
 
 States and the federal government must expand, not 
obstruct, research and implementation of 
innovative treatments for PTSD and other 
psychological and physical wounds of war,  
including treatment modalities involving Schedule I 
substances such as MDMA and marijuana. 
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Iraq and Afghanistan Veterans:  
Incarceration and the War on Drugs 
 
Roughly 140,000 veterans were incarcerated in state and 
federal prisons as of 2004 – the last year for which data 
are available, when the Iraq and Afghanistan wars were 
in their early stages.11 Tens of thousands more veterans 
are incarcerated in county jails.12   
 
These data only capture a small fraction of veterans of 
the wars in Iraq and Afghanistan, because few had 
returned home or been discharged from active service at 
the time. Sadly, the full magnitude of the problem is 
likely to emerge in the coming years and decades. As 
more veterans are discharged after longer and repeated 
deployments,13 the number of incarcerated veterans is 
likely to increase significantly.14,15  
 
One team of researchers summed up this likelihood: 
“The high rates of PTSD among veterans returning 
from Iraq and Afghanistan and the increased enlistment 
of individuals with more troubled backgrounds 
(including increased numbers with a criminal history) 
and less educational achievement, suggests that 
incarceration rates among the current cohort of AVF 
[All Volunteer Force] veterans may increase in future 
years.”16 
 
Data from a national survey of Iraq and Afghanistan 
veterans found that 9 percent of respondents reported 
being arrested since returning from service. “Most 
arrests were associated with nonviolent criminal 
behavior resulting in incarceration for less than two 
weeks….a subset of veterans with PTSD and negative 
affect may be at increased risk of criminal arrest. 
Because arrests were more strongly linked to substance 
abuse and criminal history, clinicians should also 
consider non-PTSD factors when evaluating and treating 
veterans with criminal justice involvement.”17 
 
Research shows that among the greatest predictive 
factors for the incarceration of veterans are substance 
misuse and addiction.18  Suffering from a mental health 
condition, especially PTSD, is also highly associated with 
increased risk of incarceration.19 Incarcerated veterans 
with PTSD report more serious legal problems, higher 
lifetime use of alcohol and other drugs, and poorer 
overall health than those without PTSD.20  
 
Existing literature strongly indicates that “incarcerated 
veterans may face a level of suicide risk that exceeds that 
attributable to either veteran status or incarceration 
alone.”21 Moreover, incarcerated veterans are highly 
vulnerable to death by overdose after release if they do 
not receive effective treatment.22    
 
Veterans who are convicted of criminal offenses, 
particularly drug felonies, or those who have drug use 
histories – and their families – face a wide range of 
punitive policies that limit access to social services that 
are necessary for their reentry to civilian life.23 
 
Forty-six percent of veterans in federal prison were 
incarcerated for drug law violations.  Fifteen percent of 
veterans in state prison were incarcerated for drug law 
violations, including 5.6 percent for simple possession.  
While available data is limited, research has shown that 
this figure has remained constant – with roughly 16 
percent of incarcerated veterans behind bars for drug 
law violations.24 
 
Sixty-one percent of incarcerated veterans met the 
DSM-IV criteria for substance dependence or abuse.  
Thirty-eight percent of veterans in state prison received 
less than an honorable discharge, which may disqualify 
them for VA benefits. 25 
 
 
“Veterans incarcerated for drug law violations 
received average sentences that were one year 
longer than those of non-veterans incarcerated for 
the same offenses.  
 
- United States Department of Justice, Bureau of 
Justice Statistics, “Veterans in State and Federal 
Prison, 2004.” 1,4,5,6,11 (May 2007). 
 
 
The incarceration of veterans tracks the general rates of 
incarceration in an important and unfortunate way: black 
and Latino veterans are much more likely to be 
incarcerated than are white veterans – exemplifying the 
same racial disparities inherent in the war on drugs.26 
Under current VA directives, incarcerated veterans are 
not afforded any VA care.27  This denial is a missed 
opportunity for the VA to provide critical services and 
support for veterans to recover from the psychological 
wounds that contributed to criminal activity in the first 
place. The VA should rescind its 2002 directive barring 
assessment or treatment of veterans incarcerated in U.S. 
jails and prisons, and should inform incarcerated 
veterans of all VA-community resources.28  
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Substance Abuse and Mental Illness 
Among U.S. Veterans 
 
Two and a half million men and women have served in 
the Iraq or Afghanistan wars.29 
 
Approximately 50 percent of Iraq and Afghanistan War 
veterans treated by the VA report symptoms of a 
mental illness.30  
 
Approximately 30 percent of Iraq and Afghanistan 
veterans treated by the VA report symptoms of 
PTSD.31 
 
Estimates vary, but one study found that more than 11 
percent of current conflict veterans have been 
diagnosed with a substance abuse condition.32 
 
According to the VA, 19 percent of current conflict 
veterans who have received VA care have been 
diagnosed with substance abuse or dependence.33  
 
Military personnel and combat veterans have higher 
rates of problematic substance use than their age 
peers in the general population.34 
 
Seventy-five percent of Vietnam combat veterans with 
PTSD met criteria for substance abuse or dependence 
in a national study.35 
 
Roughly one-third of veterans who seek treatment for 
substance misuse also meet criteria of PTSD.36 
 
Veterans do not qualify for substance abuse disability 
benefits unless they also have PTSD.37  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Veterans of Every Major War Have Battled 
PTSD, Addiction and Incarceration 
 
PTSD was added to the third edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-III) 
after the Vietnam War, but the disorder has existed for 
as long as soldiers have gone to war.38  What was called 
“soldier’s heart” during the Civil War, “shell shock” 
during World War I, and “combat exhaustion” or 
“combat fatigue” during World War II and the Korean 
War has evolved into what is now known as PTSD.39   
 
Symptoms of PTSD include “strong memories and 
nightmares, feeling numb or detached, and difficulty 
sleeping,”40 as well as hyper-arousal and hyper-vigilance, 
and a clinically recognized tendency to self-medicate 
with alcohol and other drugs. 41   
 
Criminal justice involvement as a result of combat 
trauma is predictable after a major war. For example, 34 
percent of new admissions to 11 U.S. prisons between 
1946 and 1949 were WWII combat veterans.42  
 
Combat veterans from Vietnam onwards face an even 
greater risk of arrest and incarceration than previous 
generations of veterans because the U.S. now 
criminalizes behaviors that were not covered under 
federal and state criminal codes until the 1970s.43 In 
particular, in 1971 ex-President Richard Nixon declared 
the war on drugs, which has persisted for more than 
forty years and led to more than forty-five million 
arrests.  
 
Consequently, in 1985, 21 percent of all men in state 
prison and 23 percent of all men in federal prison were 
veterans – a direct legacy of Vietnam and the escalating 
war on drugs.44  The largest study of Vietnam veterans, 
the National Vietnam Veterans Readjustment Study 
(NVVRS), found in 1988 that nearly half of male 
Vietnam combat veterans afflicted with PTSD had been 
arrested or incarcerated one or more times, while 11 
percent had been convicted of a felony.45   
 
PTSD and other psychological wounds of war may also 
emerge several years after returning from combat.46  
 
Experts predict a more dramatic recurrence of these 
trends as current conflict veterans return home, unless 
urgent, evidence-based responses to support veterans 
battling addiction and incarceration are implemented at 
the local, state and national levels.47   
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Harm Reduction for Veterans Facing 
Heightened Risk of Overdose and Hazardous 
Drinking 
 
Veterans who struggle with substance abuse  
and mental illness are much more likely to die 
prematurely than their peers who are not afflicted with 
these conditions.48 In particular, Vietnam veterans with 
PTSD from combat face a heightened risk of dying from 
a fatal drug overdose.49 Media and anecdotal reports 
suggest that overdose is claiming many veterans of the 
current conflicts.50 Their risk of fatal overdose is 
especially high given the widespread use of prescription 
medications, especially opioid analgesics for relief of 
pain from combat injuries51 and antidepressants for 
mental health treatment.52  
 
New data and research have proven what these media 
and anecdotal reports have demonstrated over the past 
decade: that veterans returning from the current 
conflicts are falling victim to preventable overdose when 
they come home.53, 54  A recent national study published 
in 2012 in the Journal of American Medical Association of 
more than 140,000 Iraq and Afghanistan veterans with 
pain diagnoses in the past year found that veterans with 
a co-occurring mental health diagnosis – especially 
PTSD – were significantly more likely to receive opioids 
for pain, to engage in high risk opioid use, and to be 
more susceptible to adverse outcomes, including 
overdose. In fact, the study found “those prescribed 
opioids across all mental health categories had a higher 
prevalence of all adverse clinical outcomes…[including] 
opioid-related accidents; and overdoses, alcohol - and 
non-opioid drug-related accidents and overdose, self-
inflected injuries.”55   
 
Veterans with a diagnosis of PTSD were at greatest risk 
of overdose and other adverse outcomes, the study 
found. The authors write: “Veterans with mental health 
diagnoses prescribed opioids, especially those with 
PTSD, were more likely to have comorbid drug and 
alcohol use disorders; receive higher-dose opioid 
regimens; continue taking opioids longer; receive 
concurrent prescriptions for opioids, sedative hypnotics, 
or both; and obtain early opioid refills. Finally, receiving 
prescription opioids was associated with increased risk 
of adverse clinical outcomes for all veterans returning 
from Iraq and Afghanistan, especially for veterans with 
PTSD, who were at highest risk of alcohol-, drug-, and 
opioid-related accidents and overdose, as well as self 
inflicted injuries.”56 
 
Another group of researchers found that “a significant 
number of veterans manage their pain by sharing 
prescriptions (16.3 percent), using alcohol or street drugs 
(28.9 percent) or any combination of these behaviors 
(35.3 percent).”57 Other research corroborates this, 
finding: “Veterans in care have a high prevalence of 
non-medical use of opioids that is associated with 
substance use, medical status and pain interference.”58 
The study found that this prevalence among veterans, 
especially younger veterans, was noticeably higher than 
the general population.   
 
 
“Compared with other Iraq and Afghanistan war 
veterans, those with PTSD exhibited higher-risk 
opioid use and adverse clinical outcomes, 
including injuries and overdose.”59 
 
- Journal of the American Medical Association, 
2012 
 
 
The high rate of prescription of opioids and other 
medications is now well established. A recent study 
found that over two-thirds (64 percent) of Iraq and 
Afghanistan veterans with elevated pain screening scores 
were prescribed at least one opioid in the past year. 
Forty-one percent of these veterans were prescribed 
long-term opioid medications.  Of long term opioid 
patients (who were also given stronger dose 
medications), one-third were also prescribed sedative 
hypnotics. The authors concluded that “the use of 
opioids and sedative-hypnotic therapy should be 
carefully monitored by prescribing physicians to prevent 
possible overdose or death.”60 
 
The elevated risk of overdose has likewise been 
demonstrated in the scientific literature. One of the first 
studies to specifically investigate the extent of the 
problem found that “Among patients receiving care 
from the Veterans Health Administration, death from 
accidental overdose was found to be associated with 
psychiatric and substance use disorders. The study 
findings suggest the importance of risk assessment and 
overdose prevention for vulnerable clinical 
subpopulations.” 61 The same team of researchers 
pinpointed this risk, writing, “VHA patients had nearly 
twice the rate of fatal accidental poisoning compared 
with adults in the general US population…Opioid 
medications and cocaine were frequently mentioned as 
the agents causing poisoning on death records.” 62 
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“Latest accounts estimate that approximately 
106,000 Soldiers are prescribed some form of pain, 
depression or anxiety medications. The potential 
for abuse is obvious.” 
 
– U.S. Army, “Health Promotion, Risk Reduction, 
and Suicide Prevention Report 2010 (July 29, 2010) 
 
 
Because effective treamtent is not available for many of 
these troops, the elevated risk for overdose will carry 
into civilian life after they are discharged.   
 
In addition to the many service members and veterans 
taking medicines by prescription, others may be self-
medicating with these drugs.63  Still others report being 
prescribed several of these medicines at the same time, 
sometimes with lax supervision from their doctors.64 
The VA conducted a recent audit of 20 inpatient 
rehabilitation facilities in its system and found that a 
majority did not have adequate screening policies for 
new patients, while a significant minority (roughly 10 
percent) of patients who are permitted to administer 
their own narcotics received more than a week’s supply 
at a time.65 
 
Prescription drugs are often taken alongside alcohol and 
other substances66 – practices that significantly raise the 
risk of overdose.67  
 
The experience of veterans coincides with that of the 
general population, among whom nonmedical opioid 
misuse is on the rise and increasingly linked to accidental 
death.68 Patients who have not developed a therapeutic 
tolerance to such medicines also face an increased risk of 
accidental overdose.69 
 
While the U.S. military does not divulge full records of 
the prescription drugs that service members take while 
deployed, several recent reports paint a grim picture.  
 
The Austin American-Statesman conducted an in-depth 
investigative report into the causes of death of hundreds 
of Texas veterans who passed away between 2003 and 
2011. After six months of combing through VA data 
and information obtained through the Freedom of 
Information Act (FOIA), the newspaper found that 
overdose was a leading cause of death for these veterans 
– causing more than a quarter (26 percent) of deaths of 
returning veterans, far higher than their age peers in the 
general Texas population (10 percent). While suicides 
have received much national attention, the American-
Statesman’s report found that nearly as many veterans 
died of overdose as suicide. Most veterans who 
succumbed to fatal overdose had multiple prescription 
drugs in their systems.70 
 
The army released a comprehensive report in July 2010 
documenting health risks among active-duty troops, 
which found that, in 2009, “there were 146 active duty 
deaths related to high risk behavior including 74 drug 
overdoses. This is tragic!”71  These deaths occurred at a 
rate of 13 per 100,000 – slightly higher than the 
overdose death rate among civilians.72 
 
 
 
Source: Austin American-Statesman (Sept. 29, 2012) 
 
 
 
Source: U.S. Army, “Health Promotion, Risk Reduction, 
and Suicide Prevention Report 2010 (July 29, 2010) 
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The army investigated 397 non-combat, accidental 
deaths of soldiers between 2006 and 2009.  Over 45 
percent of these – or 188 soldier deaths – resulted from 
an alcohol or other drug overdose.73  Of the 188 
accidental or undetermined deaths caused by drugs or 
alcohol from FY 2006 – FY 2009, 139 (74 percent) were 
caused by prescription drugs.74 
 
The report further concluded that the unauthorized use 
of painkillers and other prescription medications among 
active-duty military personnel tripled between 2005 and 
2008.  Five times as many soldiers reported abusing 
prescription medications as illegal drugs.75  The report 
states, “In addition to antidepressant medications, 
narcotics represent an increasing concern for the 
force…. Oxycodone (Percocet) and hydrocodone 
(Vicodin) have become the second and third most 
frequently used pain management medications.”76  
Overall, about one in seven U.S. soldiers currently have 
a prescription for some type of opioid.77 
 
The most recent official data are not fully avaialble, but 
what the army has so far analyzed shows that soldiers’ 
risk for overdose has been increasing.  Of 222 accidental 
or undetermined noncombat deaths that the army had 
reviewed as of 2010, at least 92 (41 percent) involved 
alcohol or other drug use at the time of death, and at 
least 50 (23 percent) were solely due to alcohol or other 
drug overdoses.78 
 
A Military Times investigative report – analyzing 14,000 
casualty records provided by the Defense Manpower 
Data Center pursuant to a Freedom of Information Act 
request – revealed at least 68 accidental drug deaths were 
reported by the military in 2009, more than triple the 
figure from 24 in 2001. Some type of opioid painkiller 
contributed to one-third or more of these overdose 
deaths.79   
 
In the past decade, at least 430 service men and women 
have died from alcohol or other drug overdoses.  
According to the Military Times, that means an average of 
one active-duty service member each week  is found dead 
from an accidental drug or alcohol overdose.80 
 
Analyses of Defense Department spending on 
prescription medications confirm this alarming rise in 
overdose potential.   Prescription drug orders (and 
associated spending) has more than doubled from 2001 
through 2009, reaching $280 million last, according 
Defense Logistics Agency data.81  Prescription 
medication use is far higher among young adults in the 
military health system than older peers.  For example, 
psychiatric medication prescriptions increased 42 
percent between 2005 and 2009 among people 18-34 
participating in the military’s insurance program 
(Tricare).82 
 
According to another recent survey of health providers 
for injured military personnel conducted by the U.S. 
Army Inspector, roughly a third of their patients are 
“dependent on or addicted to drugs.”83  Survey 
participants reported that between 25-35 percent of 
these wounded troops “are over medicated, abuse 
prescriptions, and have access to illegal drugs.”84  
 
In the same survey, most respondents stated that a 
majority of injured troops arrive to specialized military 
hospitals (Warrior Transition Units) with prescriptions 
they had already been given in theater or at 
demobilization sites.85 
 
The Warrior Transition Units have seen at least 30 
soldiers and two marines die from overdoses since 
2007.86 
 
 
“We’re seeing … a lot of soldiers that are taking 
narcotics, a lot of soldiers are taking anti-
depressants, psychotropic class medications.”  
 
– BG Richard Thomas, Asst. Surgeon General for 
Force Projection, “Fighting the Emotional Toll of 
War,” CNN, March 30, 2010. 
 
 
These recent reports confirm a trend that emerged early 
in the course of the two current conflicts and has only 
worsened.  A 2005 military survey found prescription 
narcotics to be the most widely misused class of drug 
among members of the armed forces.87 VA records 
reveal that prescription drugs are widely abused by 
veterans,88 especially opioid pain medications and mood 
disorder medications, such as benzodiazepines.89  
 
The Office of the Surgeon General of the U.S. Army 
Multinational Force surveyed soldiers and found that 
one in eight was taking prescription medication for a 
sleeping disorder or combat stress,90 and USA Today 
reported in late 2008 that the number of opioid pain 
prescriptions for injured troops increased from 30,000 
to 50,000 per month since the Iraq War began.91  
 
Overdose can strike anytime, but incarcerated veterans 
are acutely vulnerable, especially during the period 
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shortly after their release from jail or prison.92  
 
By far the most commonly abused drug among active 
duty military and veterans is alcohol.93  A study 
published in the American Journal of Preventive Medicine 
found that over 43 percent of active duty military 
reported binge drinking, and nearly 20 percent reported 
frequent, heavy drinking, within the past month.94  More 
than half of military personnel who binge drink also 
reported alcohol-related problems, including a 
significantly greater likelihood of high-risk behavior and 
alcohol-related violations of the law.95 
 
 
“He survived over there.  Coming home and dying 
in a hospital? It’s a disgrace.” 
 
– Father of Cpl. Nicholas Endicott, who died of an 
overdose of multiple prescription drugs, including 
opioids, after deploying twice to Iraq and once to 
Afghanistan.96 
 
 
These findings echo other studies, including a sample of 
Iraq and Afghanistan war veterans, of which 40 percent 
screened positive for hazardous drinking and 22 percent 
screened positive for possible alcohol abuse, but less 
than a third of hazardous drinkers received any risk 
reduction counseling by a VA provider.97 Another 
sample of current conflict veterans reported nearly 
identical results (39 percent probable alcohol abuse).98 
Prevalence of alcohol misuse is higher among male 
veterans of the Iraq and Afghanistan wars who accessed 
the VA healthcare system than male veterans of other 
eras.99 Iraq and Afghanistan war veterans who screened 
positive for PTSD or depression were two times more 
likely to report the misuse of alcohol compared to 
veterans who screened negative, and alcohol misuse was 
sontrogly linked to PTSD symptoms, especially 
“emotional numbing,”100 consistent with many prior 
studies finding that vetrerans suffering from PTSD self-
medicate using alcohol and other drugs.101 Rates of 
alcohol misuse were strongly correlated with levels of 
combat exposure.102 
 
Among Guards and Reservists, the likelihood of alcohol-
related problems increased with those reporting any 
mental illness or use of medication.103 A more recent 
study of National Guard members who served in the 
Iraq or Afghanistan wars similarly found high rates of 
alcohol abuse but low rates of treatment: 36 percent of 
Guard members surveyed met criteria for alcohol 
misuse, of whom only 31 percent reported any mental 
health treatment, and less than 3 percent received 
specialty substance abuse treatment. The authors 
concluded, “Rates of alcohol misuse are high and rates 
of substance use treatment are low among National 
Guard service members.”104 These findings are 
particularly troubling given the reliance on Guard and 
Reservist units to support operations in Iraq and 
Afghanistan, the prevalence of prescription medications 
for combat injuries, and the potentially lethal effect 
alcohol can have by itself or in combination with these 
medications.105 
 
 
“I have almost given up hope…I should have died 
in Iraq.” 
 
– Senior Airman Anthony Mena, before dying of an 
overdose of multiple prescription drugs, including 
two opioids, on July 21, 2009, after battling pain, 
insomnia, anxiety and post-traumatic stress 
disorder from multiple deployments to Iraq.106 
 
 
Despite the widespread and risky use patters of alcohol, 
few veterans and service personnel who misuse alcohol 
receive treatment or harm reduction servcies. According 
to one recent study, “Very few veterans who reported 
elevated alcohol consumption…received specialty 
substance use treatment in the year after being 
surveyed.”107   
 
Recommendations to Prevent Accidental Drug 
Overdose and Hazardous Drinking 
 
 VA physicians should prescribe naloxone to all 
veterans who are taking opioid pain 
medications.108,109  Naloxone is an opioid antagonist 
medication that reverses the respiratory failure that 
commonly causes death from opioid overdose.  
 
 The VA should improve patient screening, 
monitoring, supervision, and education, as well as 
physician training, to guarantee the effective 
treatment of veterans’ injuries while minimizing the 
risk of overdose or other adverse drug event.110 
 
 The VA should increase access to methadone, 
buprenorphine and other medication-assisted 
therapies among opioid-dependent veterans. When 
properly administered, medication-assisted therapies 
decrease the risk of opioid overdose, particularly 
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when made available to incarcerated veterans who 
suffer opioid dependence.  
 
 The VA, as well as state and federal correctional 
facilities, should provide comprehensive overdose 
prevention education to veterans. Prior to their 
release from jail or prison, incarcerated veterans 
should receive naloxone and training in its use.111  
 
 
"These are signs that happen prior to 
dying…Family members can fail to recognize that 
this is an impending calamity." 
 
– Dr. Lynn Webster, medical director of Lifetree 
Clinical Research and Pain Clinic,  Salt Lake City112 
 
 
 States – and even military bases – should follow the 
lead of New Mexico, Washington, Connecticut, 
New York and California and enact laws that 
provide legal amnesty to persons who report an 
overdose to emergency medical services. Research 
shows that many overdose fatalities occur because 
witnesses delay or forego seeking help out of fear of 
arrest or other disciplinary consequences.113 Medical 
amnesty policies will save lives.114 
 
 Military bases should also adopt naloxone 
distribution programs, to equip service men and 
women – and their loved ones – to respond in the 
event of an overdose.  In 2011, U.S. Army medical 
personnel at the Fort Bragg Military Installation in 
North Carolina implemented Operation Opioid 
SAFE. The program provides overdose prevention 
training and naloxone to active duty soldiers who 
are returning to the United States from overseas 
assignments and are at higher risk of opioid 
overdose.115 
 
 The VA and DoD should improve screening and 
risk reduction counseling programs for people who 
misuse or abuse alcohol.116   
 
 
 
 
 
 
 
Medication-Assisted Therapies to Treat 
Addiction, Reduce Incarceration, and Prevent 
Overdose Deaths 
 
Veterans and service people with substance abuse 
disorders face significant barriers to treatment.117 
Foremost is the inability to receive the most effective 
treatments for opioid dependence – methadone and 
buprenorphine. 
 
The Centers for Disease Control and Prevention,118 the 
Institute of Medicine119 of the National Institutes of 
Health,120 the Substance Abuse and Mental Health 
Services Administration (SAMHSA) of the U.S. 
Department of Health and Human Services,121 the 
National Institute on Drug Abuse (NIDA),122 the World 
Health Organization,123 and over four decades of 
government-funded, peer-reviewed medical research124 
have unequivocally and repeatedly proven that 
substitution therapies like methadone maintenance are 
the most effective treatments for opioid dependence.125,126  
Methadone is one of the most widely studied medicines 
and is employed effectively around the world to treat 
opioid dependence. Methadone and other substitution 
therapies lead to better health and social outcomes than 
any other treatment modality.127 Medication-assisted 
treatments are also cost effective.128  These medicines 
have been proven equally effective in treating heroin or 
prescription-type opioid dependence.129  For these 
reasons, the above-mentioned medical, research, and 
public health arms of the federal government urge 
medical professionals to use medication-assisted 
therapies to treat opioid dependence. 
 
Yet physicians on the federal payroll within  
the VA fail to prescribe these highly effective treatments 
to the majority of veterans who need them.130 The 
prerequisite physician training to prescribe methadone 
and buprenorphine is simple, inexpensive and can be 
conducted online with relative ease. Nevertheless, few 
VA physicians are given the opportunity – or the 
encouragement – to receive such training. Hospital 
administrations' lack of commitment and interest in 
buprenorphine is one reason why physicians do not 
press for these treatments for their patients. Some 
physicians – especially primary care physicians, who 
provide the majority of overall VA care – may feel ill-
informed and be deterred from prescribing methadone 
and buprenorphine. Other doctors may choose not to 
prescribe because of professional stigma.131 As a 
consequence, most veterans are left without effective 
treatment for their conditions.132 “Pharmacotherapies 
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for opioid use disorders are highly effective. Yet, in the 
case of the VA, most veterans with opioid use disorders 
still do not receive any of these highly efficacious 
treatments.”133 
 
Unfortunately, for many years the VA’s insurance 
system (CHAMPVA) and the Department of Defense’s 
insurance (TRICARE) have explicitly prohibited 
coverage of methadone and buprenorphine treatment 
for active duty personnel or for veterans in the process 
of transitioning from DoD care.134135 As a result, 
veterans obtaining care through the VA, as well as active 
and recently active military personnel receiving care 
from the DoD, are outright denied effective treatment 
for opioid dependence,136 often at a critical, early 
juncture when full-blown addiction could still be 
avoided.137 A recent article published in Military Medicine, 
for example, writes, “Opioid agonist treatment is the 
recommended first-line treatment for opioid 
dependence…[but] is generally not a treatment option 
for active duty personnel.”138  
 
The DoD requested that the federal Institute of 
Medicine (IOM) assess the adequacy of drug prevention 
and treatment in the military. The IOM released its 
findings in fall 2012, concluding that “substance use and 
abuse remain a concern for the military. Many of the 
medical conditions that prevail in a heavily deployed 
force have led to frequent prescriptions for controlled 
substances, increasing the risk for addiction or 
misuse.”139 The IOM specifically documented a shortage 
of qualified substance abuse treatment professionals in 
all military branches and components; a lack of 
confidentiality for service people who seek treatment, 
creating additional barriers to accessing needed care for 
fear of disciplinary actions or other negative effects to 
one’s military career; a lack of integration of substance 
abuse and mental health treatment services; and the 
questionable efficacy of military prevention efforts, 
especially the universal drug testing program.140 
 
One of the IOM’s strongest critiques was of the 
military’s denial of medication-assisted treatments like 
methadone and buprenorphine. The IOM writes, “Best 
practices for SUD treatment include the use of agonist 
and antagonist medications… However, the current 
TRICARE SUD benefit does not permit use of opioid 
agonist medications for the treatment of addiction and 
therefore deprives patients access to medications that 
could help reduce craving and support long-term 
recover.”141 Consequently, the IOM recommended that 
the “DoD should move forward to promote evidence-
based treatment modalities, such as the use of agonist 
and antagonist medications without restrictions.”142 
 
Another recent study came to the same conclusions as 
the IOM, writing, “At present, the active duty military 
does not permit treatment of opioid use disorders with 
medications. This policy warrants re-examination, 
particularly for military members who develop opioid 
use disorders as a consequence of treatment with 
opioids for painful conditions incurred in the line of 
service.”143   
 
In a hopeful sign, the DoD announced its intention to 
revise this misguided policy in December 2011, 
proposing a change in federal regulation to remove the 
TRICARE exclusion. In its proposed rule, the DoD 
recognized that the “prohibition of maintenance 
treatment of  substance dependence utilizing a specific 
category of psychoactive  agent is outdated and fails to 
recognize the accumulated medical  evidence supporting 
certain maintenance programs as one component of  the 
continuum of care necessary for the effective treatment 
of  substance dependence.”.144  However, after nearly 
one year, the change is still pending.145 The VA has not 
indicated that it is considering a similar for CHAMPVA. 
 
Incarcerated veterans with opioid dependency problems 
face additional risks and barriers to treatment. These 
veterans should be able to receive medication-assisted 
therapies while behind bars and, if necessary, upon 
release. Indeed, according to the National Institutes of 
Health, "… all opiate-dependent persons under legal 
supervision should have access to methadone 
maintenance therapy..."146 
 
Whereas Vietnam veterans famously struggled with 
heroin dependency, more recent veterans are at 
increased risk of becoming dependent on opioid 
painkillers.147 Regardless of when or where they served, 
all opioid-dependent veterans deserve medication-
assisted therapy. 
 
Recommendations for VA Hospital and Vet Center 
Administrators: 
 
 Require all veterans to be screened for opioid 
dependence; 
 
 Train physicians who treat veterans, including 
primary care doctors, how to prescribe methadone, 
buprenorphine, and other medication-assisted 
therapies to opioid-dependent persons;  
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 Ensure the availability of these medication-assisted 
therapies to all veterans who would benefit from 
them; and  
 
 Inform veterans that effective opioid-dependency 
treatment is available through the VA. 
 
State and federal governments, with assistance from the 
VA, should make methadone and/or buprenorphine 
available to incarcerated veterans who would benefit 
from these therapies.  
 
The DoD and VA should eliminate restrictions 
preventing TRICARE and CHAMPVA, respectively, 
from covering buprenorphine and methadone for active 
military, veterans, and their families.  
 
Effective Treatments Obstructed by the Drug 
War: Medical Marijuana and MDMA 
 
Medical Marijuana 
 
The drug war often stands in the way of effective 
treatment for veterans and threatens the therapeutic 
alliance between a patient and their doctor. One of the 
clearest cases in which the war on drugs is blocking the 
best course of treatment for many veterans is medical 
marijuana. 
 
Eighteen states – Alaska,148 Arizona,149 California,150 
Colorado,151 Connecticut ,152 Delaware,153 Hawaii,154 
Maine,155 Massachusetts,156 Michigan,157 Montana,158 
Nevada,159 New Jersey,160 New Mexico,161 Oregon,162 
Rhode Island,163 Vermont164 and Washington165 – and 
the District of Columbia166 currently provide legal 
protection under state law for seriously ill patients whose 
doctors recommend the medical use of marijuana. Some 
95 million Americans, or roughly 30 percent of the U.S. 
population, currently reside in a state where marijuana is 
legal for medical purposes.  
 
Marijuana’s medicinal benefits are incontrovertible, now 
proven by years of clinical controlled trials of the highest 
caliber. 
 
While there is a plethora of scientific research 
establishing marijuana's safety and efficacy,  the National 
Institute on Drug Abuse (NIDA) and Drug 
Enforcement Administration (DEA) have effectively 
blocked the standard Food and Drug Administration 
(FDA) development process that would allow for the 
marijuana plant to be brought to market as a 
prescription medicine.  Marijuana is the only Schedule I 
drug that the DEA prohibits from being produced by 
private laboratories for scientific research.  Although 
DEA has licensed multiple privately-funded 
manufacturers of all other Schedule I drugs, it permits 
just one facility – operated by NIDA – to supply 
marijuana to scientists. The DEA and NIDA have 
successfully created a Catch-22 for patients, doctors and 
scientists by denying that marijuana is a medicine 
because it is not approved by the FDA, while 
simultaneously obstructing the very research that would 
be required for FDA to approve marijuana as a 
medicine. 
 
NIDA has refused to provide marijuana for three studies 
with Food and Drug Administration and Institutional 
Review Board approval, including a study approved by 
the FDA last year that would have examined medical 
marijuana for veterans suffering from post-traumatic 
stress disorder (PTSD). Dr. Sue Sicely, University of 
Arizona, wants to study the effects of marijuana on 
PTSD symptoms.Unfortunately, Sisley and other 
researchers have been effectively barred from 
conducting research due to NIDA’s refusal to grant 
them a federally-approved source of research-grade 
plant material. 
 
Ample evidence indicates medical marijuana effectively 
treats PTSD symptoms167 with none of the deliterious 
and potentially dangerous side effects of many 
prescription pharmaceuticals. According to one recent 
study, “Cannabis may dampen the strength or emotional 
impact of traumatic memories through synergistic 
mechanisms that might make it easier for people with 
PTSD to rest or sleep and to feel less anxious and less 
involved with flashback memories.”168  
 
Because of the intransigence of relevant federal US 
agencies, much research into marijuana as a treatment 
for PTSD comes from abroad.  Israel, for example, has 
been at the forefront of this research.169 An open-label 
pilot study of Israeli combat veterans found that the 
“use of medical cannabis was associated with a reduction 
in PTSD symptoms.”170 
 
Several controlled, double-blind, peer-reviewed studies 
show smoked marijuana’s potential to relieve chronic, 
neuropathic pain – a difficult-to-treat type of nerve pain 
associated with cancer, diabetes, HIV/AIDS, spinal cord 
injury and many other serious conditions. These studies 
found that marijuana consistently reduced patients’ pain 
levels to a comparable or better degree than currently 
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available treatments.171  The researchers conducting the 
studies concluded, “The results from these four studies 
have been convergent, with all four demonstrating a 
significant decrease in pain after cannabis administration. 
The magnitude of effect in these studies…was 
comparable to current therapies.”172   
 
Not only is medical marijuana effective for treating 
chronic and intractable pain, but inhaled marijuana has 
also been found to complement prescription opioid pain 
medicines well, enhancing the efficacy of (and safely 
interacting with) these more powerful narcotic 
medications. An important recent study reported that 
their subjects' pain "was significantly decreased after the 
addition of vaporized cannabis", and suggested that 
cannabis treatment “may allow for opioid treatment at 
lower doses with fewer [patient] side effects."   The 
authors concluded that their results “demonstrate that 
inhaled cannabis safely augments the analgesic effects of 
opioids."173 
 
Such findings are increasingly common, prompting a 
recent journal commentary to note, "There is sufficient 
evidence of safety and efficacy for the use of [marijuana] 
in the treatment of nerve pain relative to 
opioids…[that] where medicinal cannabis is legal, 
physicians who treat neuropathic pain with opioids 
should evaluate their patients for a trial of cannabis and 
prescribe it when appropriate prior to using opioids.” 
The commentary went on to suggest that, “Prescribing 
cannabis in place of opioids for neuropathic pain may 
reduce the morbidity and mortality rates associated with 
prescription pain medications and may be an effective 
harm reduction strategy."174 
 
A recent literature review of medical marijuana’s efficacy 
for treating pain found that, of 38 studies included, “71 
percent (27) concluded that cannabinoids had 
empirically demonstrable and statistically significant 
pain-relieving effects, whereas 29 percent (11) did not.” 
Of major significance, the review concluded, ““[F]or 
notoriously difficult to treat conditions … cannabinergic 
pain medicines, particularly inhaled cannabinoid 
botanicals, are one of the only treatments that have been 
shown to be safe and effective with the highest levels of 
evidence.”175 
 
Another recent, authoritative review article summarizing 
the state of the research indicating smoked marijuana 
reduces symptoms of chronic/neuropathic pain and 
other conditions – and does so with an acceptable safety 
profile. The article recommends that doctors be allowed 
to weigh the benefits against risks of medical marijuana 
therapy – just as they do with any other medicine.176 
Not only has the scientific community confirmed 
marijuana’s medicinal benefits, but it has also concluded 
that marijuana has a wide margin of safety as a medicine, 
meaning that it typically poses fewer risks to patient 
health and well-being than many conventionally-
prescribed treatments.177 Reports by the Institute of 
Medicine, World Health Organization, and other well-
regarded scientific and medical institutions have 
demonstrated that marijuana, by contrast, is unlikely to 
produce physiological dependence, and there is no 
amount of marijuana that can result in an overdose.178 In 
the words of the IOM, “the acute side-effects of 
marijuana use are within the risks tolerated for many 
medications.”179   
 
In fact, new research suggests that marijuana may aid 
some in recovery from addictions to alcohol and other 
drugs. Confirming earlier findings, one recent study of 
medical marijuana patients found that some “have been 
engaging in substitution by using [marijuana] as an 
alternative to alcohol, prescription and illicit drugs.”180 
The top two reasons listed by participants as reasons for 
substituting marijuana were “less adverse side effects” 
(65 percent) and “better symptom management.” (57.4 
percent).  A published survey of applicants for the 
medical use of marijuana in California conducted by 
RAND Corporation similarly found that “half of the 
applicants reported using marijuana as a substitute for 
prescription drugs.”181 
 
Marijuana may also have a beneficial impact in suicide 
prevention. A group of researchers estimated the effect 
of medical marijuana laws on suicide rates. Their analysis 
revealed that “the passage of a medical marijuana law is 
associated with an almost 5 percent reduction in the 
total suicide rate, an 11 percent reduction in the suicide 
rate of 20- through 29-year-old males, and a 9 percent 
reduction in the suicide rate of 30- through 39-year-old 
males.”182 
 
However, medical marijuana’s legal status puts this safe 
medicine out of reach for many veterans.  Most veterans 
lack access to medical marijuana, forced by the drug war 
to turn to the streets to access the medicine that works 
best for them.  
 
What is more, it is well documented that veterans are 
self-medicating with marijuana to relieve PTSD 
symptoms.  As one study writes, “It seems obvious from 
more recent studies of clinical and non-clinical 
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populations that cannabis is used by a significant 
number of PTSD patients in the attempt to cope with 
their symptoms.”183 The study concluded, “Multiple 
effects associated with cannabis resin appear to act 
synergistically to reduce some symptoms of PTSD and 
might offer potentials for new psychopharmacological 
treatments. Therefore, PTSD subjects may opt to self-
medicate by using cannabis.”184 
 
Recently, the VA changed its policy and will no longer 
penalize veterans who are legally participating in a state 
medical marijuana program. Previously, many veterans 
had been cruelly denied opioid pain medications or 
other needed care just for testing positive on a drug test 
for medical marijuana – even when such use is legal in 
their state.185 Accordingly to the new VA position, 
“VHA policy does not administratively prohibit 
Veterans who participate in State marijuana programs 
from also participating in VHA substance abuse 
programs, pain control programs, or other clinical 
programs …patients participating in State marijuana 
programs must not be denied VHA services.”186  
 
However, the VA bans its doctors from recommending 
marijuana to their patients or completing state forms 
required for their patients to enroll in a state medical 
marijuana program.187 Its official policy states, “It is 
VHA policy to prohibit VA providers from completing 
forms seeking recommendations or opinions regarding a 
Veteran’s participation in a State marijuana program.”188 
Many veterans as a consequence are left with no option 
but to visit a private doctor at their own expense.  
 
The US has a duty to provide unfettered access to 
whatever medicine works best for returning veterans. To 
allow the war on drugs to hinder or prohibit access to 
such medicine is ineffective and morally indefensible. 
 
Spotlight on New Mexico 
 
New Mexico’s law, The Lynn and Erin Compassionate Use 
Act, was passed in 2007. The clear intent of the law is to 
provide relief from pain and suffering caused by 
debilitating permanent and chronic conditions. 
 
PTSD was approved as a qualifying condition in New 
Mexico in 2009. Today nearly 3,000 New Mexican 
residents with Post-Traumatic Stress Disorder are 
actively enrolled in the state’s Medical Cannabis 
Program. Thirty-seven percent of medical marijuana 
patients in New Mexico indicate PTSD as the primary 
condition for which they are seeking relief – making 
PTSD the most common medical condition for which 
New Mexico patients use medical marijuana.189 They are 
military veterans, patients living with disabilities, and 
victims of serious trauma and violent crime. More than 
175,000 military veterans call New Mexico home,190 
including some who have relocated to New Mexico 
specifically to have legal access to medical cannabis for 
PTSD.  It is not known exactly how many of these 
veterans are part of the state’s Medical Cannabis 
program.  
 
 
"I've run the gamut of all the different medications 
at the VA, and basically I was at my limit. The 
medications were turning me into a zombie, I 
couldn't relate to my daughter. Medical cannabis 
made me a father and a husband again. It's been a 
blessing." 
 
- Decorated U.S. Army veteran Paul Culkin, a New 
Mexico medical marijuana patient who suffers from 
PTSD after serving as a bomb squad staff sergeant 
in Iraq.191 
 
 
Patients deserve access to effective medical treatments – 
whether they have just come home from combat or are 
suffering debilitating symptoms from other trauma. 
Patients also deserve, above all, the freedom to choose 
the safest and most effective treatment for their 
disabling conditions. 
 
 
“When I returned home from Afghanistan I was 
diagnosed with PTSD. I worked with my doctor and 
tried many prescription drugs. Taking handfuls of 
pills every day, every one with a different set of 
side effects was hard on my body, and I still 
experienced some symptoms. Cannabis was not 
my first choice of medicine, but I tell you first hand, 
this medicine works for me. Cannabis allows me to 
leave my house and has helped me to return to 
work.” 
  
-Col. Michael Innis, Purple Heart recipient 
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Source: New Mexico Department of Health 2012. 
 
In fact, many psychiatrists report that pharmaceutical 
cocktails currently prescribed to sufferers of PTSD have 
limited efficacy, have significant debilitating side-effects, 
and have in many cases proven deadly.192 Given these 
facts, along with the experience of thousands of patients 
whose quality of life has been improved by medical 
marijuana, it should continue to be an available 
treatment for sufferers of PTSD. 
 
There is movement to include PTSD in other states with 
medical marijuana laws with regulations allowing the 
addition of medical conditions. However, thus far, 
attempts have failed in Arizona, Colorado and Oregon.  
 
 
“The right to safe and non-toxic medicine means 
much more to me than I can express in 
words.  Incorporating medical cannabis into my 
treatment for my PTSD helps me sleep, helps me 
manage my physical pain, and helps me enjoy my 
family.” 
 
- "Nathan," an Air Force veteran who suffers from 
PTSD, Las Cruces, New Mexico 
 
 
After an attempt to add PTSD as a qualifying condition 
in Colorado was denied veterans have rallied as vocal 
supporters of Amendment 64, the successful initiative 
that passed in Novermber 2012 that will regulate, tax 
and control marijuana in the state. A coalition of 
veterans’ groups in the state issued a statement saying 
that “Passage of Amendment 64 would ensure that 
Coloradans 21 and older who suffer from PTSD are no 
longer subject to arrest and prosecution for using 
marijuana. Our brave soldiers – and the many non-
soldiers who suffer from PTSD – deserve legal and safe 
access to marijuana, which has been proven to be 
therapeutically effective in treating this condition.”  
 
MDMA: Promising Research Continues Despite 
Drug War Obstacles 
 
Another currently prohibited substance that holds great 
potential for treating PTSD symptoms is MDMA.  
 
MDMA-assisted psychotherapy is an innovative 
treatment that combines traditional psychotherapy with 
the administration of MDMA (3,4-
methylenedioxymethamphetamine), a synthetic 
compound widely recognized for its ability to decrease 
fear and defensiveness while increasing trust and 
empathy.193 MDMA is an effective and powerful tool for 
both the clinician and the patient. Because of MDMA’s 
unique effect of diminishing fear and enhancing 
interpersonal trust, it appears to be an ideal adjunct 
medicine to traditional psychotherapy for PTSD. 
 
MDMA-assisted psychotherapy allows people with 
chronic, treatment-resistant PTSD to relive, and 
confront, their traumatic memories in the context of a 
safe and controlled clinical setting, and often for the first 
time. The substance is only administered a handful of 
times over the course of a year or more of therapy. 
Conventional pharmaceutical treatments for PTSD often 
have unwanted or even dangerous side effects and 
require daily administration of drugs for months or 
often indefinitely. As noted above, safe and effective 
treatment options for PTSD are limited: Only two 
selective serotonin reuptake inhibitors (SSRIs) – 
paroxetine (Paxil®) and sertraline (Zoloft®) – are 
currently marketed as PTSD medications; other 
medications such as benzodiazepines and antipsychotics, 
are being used off-label.194 The medicines have limited 
efficacy and potentially life-threatening side effects, 
especially when used in combination with opioid pain 
medications.  MDMA, like marijuana, has no such side 
effects. 
 
MDMA has been approved for use in clinical research 
and has “been administered to over 500 human subjects 
in clinical studies without a single serious adverse event 
occurring as a result of the drug.”195 A seminal 2010 
study published in the Journal of Psychopharmacology found 
that 83 percent of patients with chronic, treatment-
resistant PTSD who received MDMA-assisted 
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psychotherapy experienced a significant reduction in the 
severity of their PTSD symptoms in comparison to 
placebo, as measured by the Clinician-Administered 
PTSD Scale (CAPS).196A long-term follow-up study that 
will be published later this year reported that these 
symptom reductions were sustained, on average, more 
than three and a half years later.197 
 
 
“It’s basically like years of therapy in two or three 
hours. You can’t understand it unless you’ve 
experienced it.” 
 
-Former Army Ranger and MDMA-assisted 
psychotherapy study participant  (March 2009).198 
 
 
Such findings have been replicated by several additional 
studies.199 Another randomized controlled MDMA-
assisted psychotherapy study concluded, “This novel 
treatment method can be safely applied in an outpatient 
setting (including an overnight stay for safety reasons, 
after each MDMA session) with no drug-related serious 
adverse events occurring.”200 The researchers found that 
“there was clinically and statistically significant self-
reported (PDS) improvement... [and] CAPS scores 
improved further at the 1-year follow-up.”201 
 
Additional research studies are underway or being 
planned in the United States, Canada, Israel, United 
Kingdom and Australia. If results continue to be 
promising, MDMA-assisted psychotherapy could be 
approved by the FDA by 2020 – provided researchers 
find the necessary funding. In August 2012, the DEA 
approved an application to proceed with a revised study 
protocol of MDMA-assisted psychotherapy for veterans, 
firefighters and police officers with service-related 
PTSD.202 The study was cleared by the FDA and an 
Institutional Review Board in February 2012 and is 
currently underway.203 
 
Despite the demonstrated safety and efficacy of MDMA, 
the drug war continues to obstruct or halt the 
progression of this vital research. Researchers write, 
“There are several limitations impeding the use of 
MDMA as an adjunct to psychotherapy. Negative 
stigmatizations of the drug exist because of its common 
association with recreational drug use…”204 Before 
MDMA was made a Schedule I controlled substance, it 
was used successfully to treat Vietnam veterans with 
PTSD; it is time that MDMA’s status be reevaluated in 
light of the pressing needs of the current generation of 
veterans and others who suffer trauma.205 
 
Unlike marijuana, federal government agencies seem 
much more inclined to allow research into MDMA to 
proceed. Yet bureaucratic, legal and cultural barriers 
created by the drug war continue to slow down the pace 
of this critical research and prolong the day when all 
veterans who need it will have access to MDMA-assisted 
psychotherapy. 
 
Recommendation for state and federal government 
agencies: 
 
 States should adopt medical marijuana programs 
and ensure that PTSD, pain and other conditions 
affecting returning veterans are included as 
designated qualifying conditions for these programs. 
 
 States with existing medical marijuana programs 
should add (or retain) PTSD and chronic pain as 
qualifying medical conditions. 
 
 Federal government agencies must promote, not 
impede, research into fully understanding and 
applying the lifesaving potential of marijuana and 
MDMA to treat PTSD and other chronic 
conditions.  
 
 Federal funding for research and development of 
both of these promising treatments is warranted 
and necessary. 
 
 The federal government should refrain from 
interfering in state medical marijuana programs, and 
ultimately move toward permitting medical 
marijuana on a national level through its removal 
from the current schedules of controlled 
substances. 
 
 The VA should rescind its directive banning its 
physicians from recommending medical marijuana 
to their veteran patients or completing requisite 
forms for their patients to enroll in a state medical 
marijuana program. 
 
 Because self-medication is common among veterans 
who currently lack access to medical marijuana, the 
VA should consider changing policies that might 
penalize such veterans for positive marijuana drug 
test results. 
 
 
17Healing a Broken System: 
Veterans and the War on Drugs 
 
 
www.drugpolicy.org 
 
Towards a Health-Centered Approach to 
Helping Veterans Struggling with Drug 
Misuse: A Critical Review of Veterans Courts 
 
As states run increasingly crowded jails and prisons with 
steadily shrinking budgets,206 it is time to rethink how 
the criminal justice system handles veterans who commit 
nonviolent crimes, often as a result of untreated 
substance abuse or mental health disorders. 
Emphasizing community-based treatment over 
incarceration has proven both effective and cost 
effective. 
 
A handful of jurisdictions are moving in this direction. 
One response, perhaps the dominant approach, has 
been to allow more veterans to participate in so-called 
veteran treatment courts. In 2008, Buffalo, New York, 
began the first treatment court devoted exclusively to 
veterans.207 Using the “drug court” model and 
principles,208 the Buffalo court works with the VA and 
other support services to divert veterans charged with 
nonviolent offenses away from incarceration and into 
treatment. Upon successful completion of the year-long 
program, graduates have their charges expunged from 
their record.209 
 
Similar courts have been established in communities 
across the country.210  Such programs may operate as 
stand-alone courts, or through existing special docket 
courts.211 State and federal legislation in recent years has 
also called for the creation of court diversion programs 
serving veterans.212 
 
It is heartening that the Buffalo veterans’ court 
coordinates with the VA to provide integrated substance 
abuse and mental health services.213  Yet according to 
SAMHSA, as of mid-2009, the Buffalo court was the 
only court program that exclusively serves veterans.214  
Most others are grafted onto existing drug court 
programs.215   
 
While the desire to provide veterans with treatment 
instead of incarceration is well founded, because veteran 
treatment courts are modeled after drug courts, they 
suffer from many of the same serious shortcomings. 
 
Drug courts were certainly developed in an attempt to 
develop more humane and effective interventions in the 
lives of people struggling with drug problems. Such 
courts have undoubtedly helped many people find their 
way to a more stable and productive life outside of the 
criminal justice system.    
But the evidence to date is clear: while drug courts will 
help some, many more will continue to be arrested and 
incarcerated for their drug use.  It is imperative that 
policy makers expand the discussion of sensible drug 
policy beyond simply whether or how much to fund 
drug courts.  Indeed, it is critical that policy makers 
understand the several critical shortcomings of the 
majority of the nation’s drug courts, as underscored by 
government-funded research conducted to date. 
 
The real problem with the drug court approach is the 
fact that drug courts exist within a drug war framework. 
Drug courts claim to treat drug use as a health issue, but 
they cannot because they are required to enforce laws 
criminalizing drug use – and therefore punishment 
ultimately trumps treatment. As a result, drug courts 
have actually made the criminal justice system more 
punitive toward addiction – not less.  
 
For example, although relapse is a common and 
predictable occurrence during treatment, drug courts 
often punish people who suffer a relapse by pulling 
them out of treatment and putting them in jail for 
several days or weeks. By contrast, in a medical setting, 
relapse calls for intensified treatment.216 
 
Therefore, it is critical when localities and states 
establish drug courts (1) to also develop many other 
interventions besides drug courts and (2) to adopt court 
practices and policies that will reduce the role of 
punishment in responding to drug use.  
 
Recommendation:  Do not require a veteran to be 
arrested or to plead guilty to access treatment.   
 
To keep costs down and produce the best offender 
outcomes, it is in counties’ best interests to develop and 
expand alternatives to incarceration other than drug 
courts. Drug courts are expensive, small programs that 
suck up more resources than other alternatives and that 
can handle only a tiny fraction of potentially eligible 
people. Drug courts may also drive incarceration, since 
they depend (often quite heavily) on jail sanctions and 
ultimately send “failed” participants to serve time behind 
bars.  
 
Most diversion programs in the country, including many, 
if not all, of the emerging veterans’ treatment courts, 
require veterans to plead guilty to criminal charges 
before being directed to treatment.  
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Yet the consequences of an arrest and conviction can be 
lifelong and devastating, including disenfranchisement, 
restrictions on licensure and employment, restrictions on 
housing, denial of public benefits, disqualification for 
financial aid, inability to adopt or foster a child, a 
forfeiture of one’s assets and/or property, the loss of 
other privileges and opportunities, as well as the use of 
arrest data in background checks for employment, 
housing, and credit access.217   
 
The burdens of criminal conviction and arrest intensify 
the struggles veterans face on the road to recovery and 
rehabilitation. In 2003, an estimated 585,355 U.S. 
veterans were denied the right to vote because of a prior 
criminal conviction.218   Inability to secure housing and 
employment because of a criminal record or recent 
incarceration is a major cause of veterans’ 
overrepresentation among the U.S. homeless 
population.219 According to the National Alliance to 
End Homelessness, veterans comprise 11 percent of the 
general population, yet one in three homeless people in 
the United States today are veterans.220   
 
A better alternative to reduce drug arrests of veterans is 
to allow law enforcement officers to issue a warning 
and/or treatment referral to an individual in possession 
of a small amount of an illicit substance who does not 
pose a substantial risk to public safety, or by assigning 
case workers and services to some of the individuals 
most often arrested for these same petty offenses.  
Efforts to divert combat veterans at the intersection of 
justice systems are taking place at the local level as well. 
A number of law enforcement agencies have become 
involved in designing pre-booking diversions that are 
veterans-specific.221  
 
In these programs, local law enforcement agencies may 
divert veterans to appropriate VA care instead of 
booking and arresting them, when such a disposition is 
in the interest of the veteran and public safety. 
Importantly, pre-booking and pre-arrest diversion 
approaches may spare veterans a criminal record that 
can exacerbate the difficulties of readjustment after 
returning home. What is more, such approaches may be 
more successful in engaging and retaining veterans in 
treatment, as research has shown that veterans “who 
were recently arrested were less likely to engage in 
treatment.”222 
 
The Chicago Police Department became the first to 
design and implement a 40-hour, veterans-specific 
training program based on the Crisis Intervention 
Training model, which provides law enforcement 
officers with a set of tools to structure responses to 
community members in mental health crisis.223 These 
models follow the recommendations of SAMHSA and 
other experts that identify several points for intervention 
among veterans along the justice continuum, including 
at first contact with local law enforcement.224  The Los 
Angeles and San Francisco Police Departments have 
begun similar efforts.225 
 
Seattle’s Law Enforcement Assisted Diversion 
(LEAD)226 and San Diego’s Serial Inebriate Program 
(SIP)227 are additional examples of such pre-arrest 
diversion programs in action for the general public. 
 
More generally, states and localities should implement 
and expand pre-plea and pre-conviction diversion 
programs for people arrested for a low-level drug 
offense in order to prevent the collateral consequences 
that hinder those with a past conviction, including 
barriers to employment228, public housing, welfare and 
student loans.229 
 
Recommendation: Create a continuum of 
interventions.  
 
Diversion programs should exist along a continuum – 
from pre-arrest, pre-plea and pre-conviction diversion 
and advancing to post-conviction diversion – in order to 
reduce criminal justice involvement and stretch limited 
resources the furthest.230 
 
State and local governments should work to leverage all 
available resources to expand access to treatment, for 
example, by: 
 
  allocating a sizeable percentage of realignment 
funds to support services, including drug 
treatment;  
 including alcohol and drug treatment services 
in your county’s healthcare reform plans231;  
 directing federal Byrne Justice Assistance 
Grants; and/or  
 diverting civil asset forfeiture funds to drug 
treatment.232 
 
Above all, these governments should expand access to 
alcohol and other drug treatment outside of the criminal 
justice system and for pre-arrest, pre-plea and pre-
conviction diversion, in order to reduce costs to the 
criminal justice system and allow health systems to more 
effectively manage these health issues.233 
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Recommendation: Embrace medication-assisted 
therapies 
 
Local and state governments should expand and protect 
access to demonstrated alcohol and other drug 
treatments, including medication-assisted treatments 
(such as methadone and buprenorphine), where 
medically indicated234. Many, if not most drug court 
programs refuse to allow clients to participate in or 
remain on methadone, buprenorphine or other 
medication-assisted therapies,235, 236 despite the fact that 
the National Association of Drug Court Professionals 
(NADCP) urges its members to make use of 
medication-assisted therapy.237  
 
Such prohibitions belie uncontroverted medical evidence 
(and the recommendations of federal agencies and 
commissions as well as the professional body 
representing every drug court in the country). More 
importantly, such prohibitions are a certain recipe for 
high rates of drug relapse and criminal recidivism.238 
Drug courts must allow clients who would benefit from 
medication-assisted therapies to access them without 
prejudice. 
 
 
“Medications such as methadone, buprenorphine, 
and naltrexone have been shown to clearly 
improve treatment outcomes for opioid-addicted 
individuals over detoxification followed by 
counseling and rehabilitative services alone. 
Similarly, naltrexone, acamprosate, and disulfiram 
have been shown to improve the outcome of 
treatment for alcohol dependence… The data fully 
justify the conclusion that medications should be 
considered as an integral part of any drug court 
treatment program. Given these data, to deny drug 
court participants the option of receiving 
medications for their treatment is in our opinion 
unethical.”239 
 
- National Drug Court Institute, National 
Association of Drug Court Professionals 
 
 
Recommendation: Reserve drug treatment for those 
who need it 
 
Drug treatment should be reserved for those who need 
it, and treatment approaches should be tailored based on 
individual needs240; with a variety of other interventions 
and non-incarceration sanctions made available for 
people arrested for a low-level drug offense or who have 
a positive drug test but who do not need treatment. 
 
Recommendation: Improve drug court practices. 
 
It’s critical that local and state governments implement 
policies that protect the rights and improve the 
outcomes of veterans in the criminal justice system, 
which translates into more effective and cost-effective 
policies.  
 
Recommended policy improvements to drug and 
other “problem-solving” courts: 
  
 Reserve drug courts for the people who commit 
more serious non-drug offenses that appear to be 
motivated by addictive-behavior241 – not the people 
who commit simple felony drug possession offenses 
– and for those who pose a higher risk to public 
safety or who have lengthier criminal histories242 [to 
cut incarceration costs significantly and to keep 
more serious offenders under close supervision, 
rather than those with a history of only petty 
offenses like drug possession];  
 
 Adopt objective admission criteria and reduce the 
prosecutor’s role as gate-keeper.243 Drug courts 
tend to operate by the rules and practices imposed 
by a particular judge and drug court team. Thus, 
drug courts vary widely between, and sometimes 
within, jurisdictions in terms of the clients they 
accept, the treatment they offer, the sanctions they 
impose, and their requirements for successful 
completion.244 Many drug courts “cherry pick” for 
the least-addicted or “easiest” offenders to inflate 
their success rates. As a matter of fairness, drug 
courts should adopt more uniform standards of 
operation and criteria for admission.245 As a matter 
of public safety and fiscal efficiency, drug courts 
should dedicate their limited judicial and treatment 
resources for the more seriously addicted offenders 
with more extensive criminal histories, who require 
the most intensive treatment and supervision.246 
Less expensive and restrictive diversionary options 
than drug court should be provided for veterans 
who commit minor offenses.247 
 
 Use a pre-plea rather than a post-plea model248 [to 
prevent the barriers that accompany a criminal 
record]. To minimize or avoid the effect of 
collateral sanctions and consequences, new 
veterans’ treatment court programs—and those 
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already in operation—should adopt deferred 
adjudication or deferred sentencing procedures. 
Also known as pre-plea or pre-adjudication 
diversion, such programs allow a defendant to enter 
treatment without pleading guilty or receiving a 
sentence of guilt. If he or she succeeds in treatment, 
the charges are dismissed. According to the 
National Association of Criminal Defense Lawyers, 
“A pre-plea, pre-adjudication program preserves 
due process rights, allows defendants an 
opportunity to seek treatment … provides a strong 
incentive for successful completion … [and] 
permits informed, thoughtful decision-making by 
defendants and counsel.”249   
 
 Limit the use of incarceration, including “flash 
incarceration,” as a response to low-level drug 
offenses and positive drug tests, and provide 
services or other sanctions instead, in order to 
reduce costs and improve outcomes for people 
convicted of drug offenses.250 Short jail sentences 
for participants who relapse during treatment are a 
central and common practice of most drug 
courts.251 The efficacy of jail sanctions (as opposed 
to non-jail sanctions) is not supported by research 
evidence.252 Moreover, the harms posed by jail are 
manifest: drugs, risky drug-taking behaviors, 
infectious diseases, violence, and stress are endemic 
to the nation’s jails. 253 In short, jail sanctions – even 
short term – are unlikely to help and may 
compromise the physical and mental health of 
veterans.254 Accordingly, incarceration should play 
no role in efforts to provide substance abuse or 
mental health treatment;255 indeed, “each instance 
of incarceration may actually increase the likelihood 
of future incarcerations.”256 
 
 Ensure due process protections and enhance the 
role of defense counsel.257 
 
 Evaluate individuals’ success based on several 
measures (including stability, employment, and 
family participation); do not use drug tests as the 
singular measure of “success” or “failure”.258 
 
 Improve data collection, research rigor, and 
implementation of demonstrated best practices.259 
No systematic, much less uniform, collection or 
evaluation of drug court data exists. As a result, 
little is known about how they operate, whom they 
serve, or how well they perform.260 In other words, 
drug court programs largely operate without 
meaningful oversight or accountability. Drug courts 
must begin keeping reliable data and have 
independent evaluators assess that data to 
determine how effectively drug courts are providing 
needed treatment, reducing criminal recidivism, 
improving client functioning and employability, 
promoting healthier lifestyles, reuniting families, 
and saving taxpayer dollars.261 
 
 Improve overall treatment quality and employ 
opioid maintenance treatments and other evidence-
based therapies. 
 
 Use drug tests as a treatment tool, not as 
punishment. 
 
 Empower treatment professionals in decision-
making. Most drug court judges are not trained as 
treatment professionals and possess no specialized 
knowledge of alcohol or other drugs.262 
Nevertheless, drug court judges frequently decide 
the type and length of treatment clients receive 
without adequate input from or deference to the 
considered opinions of substance abuse and/or 
mental health professionals. Courts should 
require—and follow—the recommendations of 
qualified health professionals who have adequately 
assessed the needs of the client.263   
 
 Reduce turnover of trained and experienced court, 
probation and treatment staff to improve program 
continuity and consistency. 
 
 Ensure that punishment for “failing” the program is 
not worse than the original penalty for the offense. 
 
 Work to establish other local alternatives outside 
the drug court for those who want and need access 
to treatment but do not warrant intensive court 
resources (e.g., probation-supervised treatment). 
 
In conclusion, governments should develop alternatives 
to court-based diversion, and reserve veteran courts for 
more serious offenders while improving those courts’ 
practices.  
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Conclusion  
 
Post-traumatic stress disorder and traumatic brain injury 
have been called the “signature wounds” of the wars in 
Iraq and Afghanistan.264 Substance abuse, too, must be 
counted among the signature wounds of the current 
conflicts. Returning veterans suffering from these 
wounds have increasingly become casualties of the U.S. 
war on drugs, a war that emphasizes punitive measures 
such as incarceration over treatment and rehabilitation.  
 
The VA system holds great promise for delivering 
integrated, individualized treatment programs that 
address the PTSD-, TBI- and substance abuse treatment 
needs of veterans.265 But much work remains to be done 
by the VA, the DoD, other public and private health 
providers, and criminal justice agencies.  
 
These bodies must improve and greatly accelerate efforts 
to prevent veterans from succumbing to drug overdoses, 
and include incarcerated veterans in national suicide 
prevention efforts.266  
 
They must also expand and improve access to 
methadone, buprenorphine, and other medication-
assisted therapies for veterans who are opioid 
dependent, whether they are in community-based 
treatment or behind bars.  
 
Veterans must have access to the safest and most 
effective treatment for their condition. For many 
veterans, such treatment includes medical marijuana or 
MDMA. State and federal government agencies should 
accelerate, not impede, research into these highly 
promising interventions. However, sufficient evidence 
already exists to support a dramatic expansion of these 
medications to all veterans currently in need. 
Accordingly, state and federal government agencies 
should ensure that patients have safe access to these 
treatment options.  
 
Finally, drug courts, which are increasingly opening their 
doors to veterans, should be considered as only one of 
several interventions to meet the varied and unique 
needs of veterans in the criminal justice system. 
Governments should expand access to community-
based treatment and explore pre-arrest diversion 
schemes instead of relying exclusively, or primarily, on 
expensive and unproven veterans’ courts. Veterans’ 
treatment court programs should only be  part of a 
broader continuum of treatment alternatives and should 
operate on a pre-plea or pre-adjudication basis, so that 
veterans can be spared the lingering collateral 
consequences of justice involvement and better 
reintegrate into society without barriers to employment, 
education, housing, and other basic needs. If such courts 
are established, they should improve upon the practices 
of drug courts and serve veterans with more serious 
offenses. 
 
Nearly all of the recommendations contained in this 
report were endorsed in 2010 by the US Conference of 
Mayors, representing our nation’s cities. Ranging from 
alternatives to incarceration to allowing veterans access 
to methadone, medical marijuana and other promising 
treatments, to urgently preventing overdose, the nation’s 
mayors issued a resolution calling on state and federal 
government entities to ensure veterans receive adequate 
treatment, rather than being criminalized and falling 
victim to the war on drugs.267 
 
In pursuing these goals, we can begin replacing the failed 
war on drugs at home with proven, effective public 
health approaches that save lives while building stronger 
families and communities. The veterans of our foreign 
wars deserve no less; indeed, they deserve a great deal 
more. 
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